Surgical treatment of chronic pancreatitis using Frey's procedure: a Brazilian 16-year single-centre experience  by Gestic, Martinho Antonio et al.
ORIGINAL ARTICLE
Surgical treatment of chronic pancreatitis using Frey's procedure:
a Brazilian 16-year single-centre experience
Martinho Antonio Gestic, Francisco Callejas-Neto, Elinton Adami Chaim, Murillo Pimentel Utrini, Everton Cazzo &
Jose Carlos Pareja
Department of Surgery, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil
Abstracthpb_281 263..271
Background: Surgical treatment of chronic pancreatitis is indicated for intractable pain. Frey's proce-
dure is an accepted treatment for this disease. The aim of the present study was to describe a
single-centre experience in the treatment of chronic pancreatitis using Frey's procedure.
Methods: A retrospective analysis of 73 patients who underwent a Frey's procedure between 1991 to
2007 and had at least 1 year of follow-up. Demographics, indication for surgery, peri-operative compli-
cations and late outcomes were analysed.
Results: The median age was 39.9 years. Seventy out of the 73 (95.8%) patients were male. The median
pre-operative body mass index (BMI) was 19.1 kg/m2. All patients had abdominal pain, 34 (46.6%) of
them daily and 13 (17.8%) weekly, with moderate or severe intensity in 98.6% (n = 72). The aetiology was
secondary to alcohol in 70 patients (95.9%), with a median consumption of 278 g per day. The surgical
morbidity rate was 28.7%; there were no deaths. Median post-operative follow-up was 77.0 months; 64
patients (91.4%) had complete pain relief and post-operative BMI was 22.4 kg/m2 (P < 0.001). All patients
with pre-operative endocrine and exocrine insufficiencies showed no reversal of the situation. New onset
insufficiencies appeared late.
Conclusions: Frey's procedure was a safe and effective therapeutic option for the surgical treatment of
patients with intractable pain caused by chronic pancreatitis.
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Introduction
Chronic pancreatitis (CP) is a progressive inflammatory disorder
characterized by irreversible destruction of pancreatic paren-
chyma, associated with disabling chronic pain and permanent
loss of exocrine and endocrine function.1 The management of
patients with chronic pancreatitis remains a challenge because of
the limited understanding of the pathophysiological process
of the disease, the unpredictability of clinical evolution and
the controversies between diagnostic criteria and therapeutic
options.2
Worldwide themain aetiological factor is alcohol abuse, and the
most common symptom is relentless chronic abdominal pain.3
After optimization of symptoms with analgesics and enzyme
supplementation, patients with persistent symptoms are candi-
dates for invasive treatments.4,5 Previous studies have shown that
surgical treatment of chronic pancreatitis reduces pain and sub-
sequent complications, so that patients return to their prior work
activities as well as improved quality of life.6–10 There is also evi-
dence that early surgical duct decompression in patients with a
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dilated pancreatic duct and with relatively preserved glandular
function can delay the onset of pancreatic exocrine and endocrine
failure.11,12
Historically, the procedures have been classified into two catego-
ries: (i) ductal decompression or (ii) partial (proximal or distal) or
total pancreatectomy. In recent decades, procedures combining
resection and decompression have evolved, such as the surgeries of
Beger13,14 and Frey15 (Fig. 1). Both have subsequently proved to be
safe and effective, providing long-term pain relief with low peri-
operative and long-term morbidity and mortality.6,7,16–35
The aim of this retrospective study was to describe a 16-year
experience using Frey’s procedure in a consecutive series of
patients from a single institution.
Methods
Between January 1991 and December 2007, patients who under-
went a Frey’s procedure for the treatment of chronic pancreatitis
at the University Clinical Hospital were studied.
The diagnosis of chronic pancreatitis was based on the findings
of clinical history, physical examination and radiological investi-
gation. Radiological investigation consisted of a combination of
ultrasonography (US), computed tomography (CT), magnetic
resonance (MR) or endoscopic retrograde cholangiopancreatog-
raphy (ERCP).
Exocrine pancreatic insufficiency was defined as the presence of
more than 10 g of fat in faeces collected for 3 days after ingestion
of 100 g of fat per day during this same period.36 Endocrine pan-
creatic insufficiency was determined according to the American
Diabetes Association, which determines the diagnosis of diabetes
for glucose levels >126 mg/dl and glucose intolerance for levels
between 100 and 126 mg/dl.37
Patients meeting the following criteria were considered eligible
for surgery: presumed diagnosis of CP, clinical intractability of
abdominal pain, an enlarged pancreatic head using radiological
criteria, Wirsung’s duct 5 mm and recommendation of alcohol
abstinence for at least 3 months. Exclusion criteria were an atro-
phic pancreatic head and a high suspicion of malignancy. Portal
hypertension was not a contraindication for the procedure.
Pre-operatively patients with poor nutritional status were iden-
tified and assessed by nutritionists. Patients with a pre-operative
serum albumin <3.5 g/dl were defined as hypoalbuminemic and
when <3.0 g/dl they received nutritional support with enteral
and/or parenteral nutrition support for 5 to 7 days before surgery.
Pain control was achieved with staggered administration of anal-
gesics, sparing opioids and its derivatives for patients with more
severe pain. Thromboprophylaxis with low-molecular-weight
heparin and antibiotic prophylaxis with 2 g of cefazolin were per-
formed at induction of anaesthesia.
All procedures were elective and performed by the same surgi-
cal team (3 surgeons) during the study period. Surgical technique
followed recommendations described by Frey and Smith15
(Fig. 2). After extensive mobilization of the pancreatic head with
Kocher’s manoeuver and exposure of the pancreas body and tail,
Wirsung’s duct was identified and opened throughout its length.
At the head of the gland, the pancreatic tissue was excised prima-
rily with a knife, preserving a thickness of about 5 mm at the
edges, and excavated down to the level of the pancreatic duct in
depth; Santorini’s duct and uncinate process tissue were excised.
After the first year, cholecystectomy was performed and the bile
duct was explored with Bakes dilators and/or transcystic cholan-
giography was performed to evaluate patency. The anastomosis
between the pancreas and a transmesocolic Roux-en-Y loop was
performed with a single layer of absorbable serosubmucosal
sutures (polyglactin). A drain was placed adjacent to the pancre-
atic anastomosis. Patients with bile ducts >1.5 cm or with insuf-
ficient decompression underwent a biliary bypass. Early in the
series, in this situation, a choledochoduodenostomy was per-
formed thus preserving the Roux-en-Y loop exclusively for pan-
Figure 1 Illustration of Frey's technique: enucleation of the head of
pancreas and uncinate process in continuity with opened Wirsung
duct
Figure 2 Complete anterior resection of the head of pancreas and
ductotomy of Wirsung in calcified gland like recommended by Frey's
technique
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creatic anastomosis. However, as experience with the technique
increased, the technique of choice became a choledochojejunos-
tomy to the same Roux-en-Y limb as the pancreatic anastomosis.
All excised tissue was weighed and sent for histopathology.
Post-operative mortality included overall in-hospital deaths.
Minor and major complications were recorded. A pancreatic
fistula was defined according to the parameters of the Interna-
tional Study Group on Pancreatic Fistula (ISGPF).38
Post-operatively all patients were asked to classify their pain as
mild, moderate and severe or no pain. Patients were also asked to
repeat endocrine and exocrine function tests. Only patients with
at least 12 months of post-operative follow-up were included.
This research was submitted and approved to the University
Research Ethics Committee and was carried out with the patients’
consent.
Data are expressed as median and ranges for continuous vari-
ables or as percentage for categorical data. For comparison of
numerical measurements between two groups we used theMann–
WhitneyU-test and between three groups the Kruskal–Wallis test.
Results were considered to be significant when P < 0.05. The data
were analysed using the SPSS® v.11.5 statistical program (SPSS
Inc., Chicago, IL, USA).
Results
Between January 1991 and December 2007, 73 patients were iden-
tified who underwent a Frey’s procedure for the treatment of
chronic pancreatitis at the University Clinical hospital. Seventy
(95.9%) out of 73 patients were male. The median age was 39.9
(range, 24–69) years; 48 (65.7%) patients were Caucasian and 10
(13.7%) were Black. The aetiology of CP was alcohol abuse in 70
patients (95.9%) and idiopathic in 3 patients. The alcoholic
patients had a median alcohol consumption onset of 19.3
(range, 7–54) years-old, and maintained the addiction during
18.0 (range, 5–40) years,with amedian daily consumption of 278 g
(range, 72–640 g) of alcohol per day. A typical Brazilian liquor
named cachaça was the most consumed drink (72/73 patients).
Smoking was present in 69 patients (94.5%),with initiation at 15.4
(range, 7–31) years-old, and use during 23.4 (range, 9–60) years of
23 (range, 10–60) cigarettes per day.Only two patients reported the
use of narcotics; both were cocaine dependent.
All patients presented with abdominal pain; 34 (46.6%)
patients daily, 13 (17.8%) weekly and 26 (35.6%) monthly. Most
patients had severe (n = 30) or moderate (n = 42) pain for a period
of 16.5 (range, 3–96) months. Analgesics were used continuously
by 64 patients (87.7%), and 32.9% (n = 24) of patients were
dependent on opioids. Forty-three (58.9%) patients had been
hospitalized because of a pain crises or episodes of exacerbation of
pancreatitis, with a median of 1.9 (range, 1–15) hospitalizations
per patient. Patients presented a mean body mass index (BMI) of
19.0 (range, 14.4–24.8) kg/m2 and pre-operative weight loss of
10.1 (range, 0–30) kg. Cholestasis and jaundice affected 41.1%
(n = 30) of patients; 9 patients had a previous diagnosis of chole-
cystolithiasis. Forty-three patients (60.3%) had comorbidities;
anemia (n = 17; 23.3%), hypertension (n = 14; 19.2%) and diabe-
tes (n = 11; 15.5%) were the most frequent. Alcohol abstinence in
the pre-operative period was followed by 57 patients (78.1%), for
a median of 7.0 (range, 1–72) months, resulting in improvement
of symptoms in 61.4% of patients (n = 35), who presented mostly
with little (n = 21) or moderate (n = 11) in pain intensity. Among
the patients who were abstinent from alcohol pre-operatively,
despite reporting improvements in intensity and frequency of
pain, 69 patients (98.6%) still rated their pain as moderate or
severe, and 45 patients (64.4%) presented with daily or weekly
episodes. Although there were clinical improvements with the
discontinuation of alcohol abuse, it did not improve symptoms
enough to reverse the indication of surgery in these patients.
Pre-operatively 17 patients (23.3%) were hypoalbuminemic
(<3.5 g/dl).
The median operative time was 319 (range, 240–480) minutes
and blood loss was 780 (range, 300–2500) ml; 43.8% (n = 32) of
patients required a median transfusion of 1.9 (range, 1–5) units of
blood during hospitalization. The median size of the head of the
pancreas was 6.0 (range, 4–10) cm, and a pancreatic duct diameter
of 8 (range, 5–15) mm; cysts were found in 36 patients (49.3%).
Excised tissue presented with a median weight of 14.8 (range,
7–78) g.
The main intra-operative complications are shown in Table 1.
Additional procedures performed are shown in Table 2. Three of
13 patients who underwent a biliary bypass had complications
(two pneumonias and one pancreatic fistula). Patients who suf-
fered intra-operative complications were more likely to suffer a
post-operative infectious complication than those that did not
(7/20 patients with intra-operative complication vs. 5/53 patients
with no intra-operative complication; P = 0.03). In those who
underwent biliary bypass there was no significant increase in post-
Table 1 Intra-operative complications during the procedure (73 Frey's procedures)
Complication No. of patients (%) Management
Transection of intrapancreatic
common bile duct
9 (12.3) Pancreatocholedochostomy (n = 3) and
proximal biliary bypass (n = 6)
Splenic injury 4 (5.4) Splenectomy
Duodenal injury 4 (5.4) Suture
Portal vein injury 2 (2.7) Suture
Colon injury 1 (1.4) Suture
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operative complications (4/13 patients with biliary bypass vs.
16/60 patients without biliary bypass; P = 0.51) or post-operative
infections (3/13 patients with biliary bypass vs. 10/60 patients
with no biliary bypass; P = 0.83).
The overall morbidity rate was 28.7% (n = 21) (Table 3). There
were five patients with pancreatic fistulae, all of them grade B by
ISGPF classification; they were treated conservatively with total
parenteral nutrition, antibiotics and octreotide, with benign evo-
lution. Two reoperations as a result of bleeding were performed,
the first one was in post-operative day 2 because of bleeding in the
spleen and retroperitoneum, and the other one was in post-
operative day 12 because of bleeding from the pancreatic excised
face (no fistula). In these two patients the pancreatojejunostomy
was taken down, the haemorrhage controlled and anastomosis
was redone. Postoperative ileus was themost frequent minor com-
plication (n = 5; 6.8%). There were no deaths. The median hos-
pital stay was 10.6 (range, 6–42) days. Using univariate analysis
(Table 4) only intra-operative intercurrences were associated
with increased post-operative complications and infections.
Other factors analysed had no relation with the post-operative
morbidity.
The follow-up was 77.0 (range, 12–204) months. Late biliary
complications occurred in six patients (8.2%). One patient devel-
oped choledocholitiasis which was treated surgically, and five
patients (6.8%) developed stenosis of the distal biliary tract of
which, three were treated endoscopically and two surgically (cho-
ledochojejunostomy).
At the time of the last follow-up visit, 91.4% (n = 64) of
patients described complete pain relief, 7.1% (n = 5) described
occasional episodic pain but did not take analgesics routinely.
Only one patient had pain recurrence 2 years after surgery; he
had been abusing alcohol and drugs. The median weight
regain of the operated patients was 9.4 (range, 1.2–22) kg, and
there was statistical difference between the BMI of patients
before and in the last clinical evaluation after the procedure
(19.0; range, 14.4–24.8 kg/m2 vs. 22.4; range 14.5–30.5 kg/m2,
P < 0.001).
All patients with pre-operative endocrine (n = 11; 15.5%) and
exocrine (n = 19; 27.2%) insufficiencies showed no reversal of
these conditions. As for patients classified as normal endocrine
function (n = 29; 40.8%) before the procedure, 19 patients
remained the same; those who developed diabetes (n = 10), pre-
sented the disease later (Fig. 3). Overall, by the end of the study,
36.7% (22/60) of the patients had developed new onset diabetes
during a median follow-up time of 59.7 (range, 3–180) months
after surgery. In patients with glucose levels 100 mg/dl but
without specific treatment (classified as intolerants or hypergly-
cemics) diagnosis of diabetes seemed to be more precocious, but
the sample appeared to be small because there was no statisti-
cally significant difference in diabetes onset between groups
(P > 0.05). Four of eleven patients with pre-operative diabetes
maintained glycaemic control with the same treatment before
surgery whereas seven patients required an escalation in their
treatment.
The effect of exocrine insufficiency is shown in Fig. 4. Of the
patients who presented pre-operatively with exocrine insuffi-
ciency at surgery (n = 19), 10 required an escalation in the dosage
of supplemental enzymes, seven of them within the first year.
Table 2 Additional procedures during Frey's operation (n = 73)
Additional procedures No. of patients (%) Commentary
Cholecystectomy 66 (90.4) Routine additional procedure actually
Biliary bypass 13 (17.8) When biliary decompression is insufficient or intrapancreatic bile duct injury
Choledochoduodenostomy 9
Choledochojejunostomy 4
Splenectomy 8 (10.9) Intra-operative injury or surgical tatic for exposure distal pancreas
Thorax drainage 3 (4.1) In cases with pancreatic pleural effusion
Partial distal pancreatectomy 2 (2.7) Surgical tatics for exposure distal pancreas
Table 3 Overall morbidity in 73 consecutive patients undergoing
head excavation of the pancreas and lateral pancreatojejunostomy
Major complications No. of patients (%)
Pancreatic leak 5 (6.8)
Infectious: 10 (13.7)
Pneumonia 4
Wound 2
Venous central catheter 2
Urinary tract 2
Pulmonary: 2 (2.8)
Pneumothorax 1
Atelectasis 1
Hepatic insufficiency 1 (1.4)
Reoperation: 3 (4.1)
Bleedding 2
Gallbladder perforation 1
Minor complications No. of patients (%)
Ileus 5 (6.8)
Delayed gastric emptying 1 (1.4)
Ascites 2 (2.7)
Cardiologic event 1 (1.4)
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The proportion of patients with normal pancreatic function
decreased from 65.7% at the time of surgery to 48.6%, 35.7% and
24.3% at 1-, 3- and 5-years post-operatively, respectively. The
breakdown is shown in Fig. 5.
Statistical analysis shows that there was no difference in the
post-operative endocrine and exocrine functions results related to
duct diameter, resected gland weight and alcohol abuse recurrence
(P > 0.05). Patients with pancreatic ducts larger than 10 mm
presented more diabetes pre-operatively (P = 0.04).
Twenty-three patients (32.9%) returned to alcohol abusive
intake after surgery; 14 patients of this group (60.9%) returned to
addiction early in the first post-operative year. The median intake
of this group was 159.6 (range, 8–480) g of alcohol per day.
Discussion
Surgical intervention for chronic pancreatitis is commonly
accepted as the most effective therapeutic option for pain control
and management of complications.39 However, choosing the
optimal intervention is still a challenge.40
Although lateral Roux-en-Y pancreatojejunostomy
(Partington–Rochelle’s technique41) has become the procedure of
Table 4 Statistical analysis of the relationship between patient characteristics and the occurrence of complications and infections in the early
post-operative period, expressed as P-value (significant P > 0.05)
Frequency Post-operative
complications (n = 21)
Post-operative
infection (n = 10)
Pancreatic
fistula (n = 5)
n P-value n P-value n P-value
Jaundice 30 7 0.29 4 0.75 1 0.64
Comorbidity 43 14 0.72 7 1.0 4 0.64
Hypoalbuminemia 17 7 0.18 5 0.05 1 0.73
Biliary stent 4 1 1.0 4 1.0 1 0.25
Wirsung duct >10 mm 7 2 1.0 1 1.0 1 0.40
Portal hypertension 8 2 1.0 2 0.61 0 1.0
Biliary bypass 13 5 0.51 2 1.0 1 1.0
Intra-operative complications 22 8 0.44 7 0.03 2 0.63
Splenectomy 8 1 0.42 1 1.0 0 1.0
Blood transfusion 37 13 0.34 6 0.95 4 0.35
Head size of the pancreas* – – 0.28 – 0.74 – 0.18
Excised tissue (amount)* – – 0.47 – 0.86 – 0.07
* Numerical variables.
Bold indicates significant P-values.
NORMALS
29 patients
(40.8%)
• DM+: 10 patients
• Normal: 19 patients
• DM+: 7 patients
• DM+: 5 patients
• Normal: 7 patients
• Normal: 11 patients
• Cure: No
• New cases: 22/60 patients (36.7%)
• Total: 33/71 patients (46.5%)
• Intolerants: 1 patient
(median follow-up in diagnosis:59.7 months)
(median follow-up in diagnosis:37.5 months)
(3 patients diagnosed before 36 months)
GLUCOSE INTOLERANTS
15 patients
(21.1%)
HYPERGLICEMIA
16 patients
(22.5%)
DIABETICS (IN TREATMENT)
11 patients
(15.5%)
Figure 3 Endocrine function evolution of patients during follow-up
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choice for ductal decompression since the second half of last
century, it is clear that this is not a technique that solves all prob-
lems for patients with CP, especially those when there is no pan-
creatic duct dilatation or the disease is predominantly located in
the head of the gland.6 In addition, several series had described
that although remission of pain occurs in up to 80% of patients at
3 years, approximately 30% of patients subsequently develop
recurrent pain after this period of time.16–18 This late pain recur-
rence was often attributed to persistence or relapse of the disease
in the pancreatic head.42 Later it became clear that the main cause
of Partington–Rochelle’s procedure failure is the absence of
adequate decompression of the proximal main pancreatic duct,
uncinate process and secondary head ducts within the head of the
pancreas.19
The surgery most often used in the treatment of chronic pan-
creatitis since 1950 was pancreatoduodenectomy, which has
proved to be effective in controlling pain and complications of
chronic pancreatitis.6,20–24 More recent studies have reported pain
remission of between 71% and 89% of patients at 4 to 6 years, with
mortality reduced to less than 5% in referral centres, but main-
taining surgical morbidity rates of around 40%.6,20,21 Even with the
modification of Longmire and Traverso,28 which contributed sig-
nificantly to the reduction in morbidity and mortality of pancre-
atoduodenectomy, glandular function deterioration remained a
problem which developed in 50% of the patients.34,35
In this context, the mixture of the two techniques has been
proposed by Beger13 and Frey,15 combining in a less aggressive
form decompression with ductal pancreatic resection with pres-
ervation of duodenum. Both techniques showed similar results in
randomized controlled trials, but Frey’s technique facilitated post-
operative morbidity.9,43,44 In a randomized and prospective study
comparing the two techniques in 40 patients, Buchler et al.
showed similar post-operative morbidity (15–20%) and hospital
stay (13–14 days).8 Most CP patients candidates for surgical treat-
ment are in a poor general condition, with diabetes and are mal-
nourished, and therefore are at higher risk of post-operative
complications. Thus, a less aggressive technique that leads to lower
post-operative morbidity benefits this population.
The present series shows the experience of a single centre in the
care of patients suffering from CP who underwent a specific sur-
gical technique, the Frey’s procedure. The overall morbidity and
mortality in this study is in agreement with recent studies that
show overall morbidity ranging from 7.5% to 39% and mortality
of 0 to 2.4%.9,45–49
Haemorrhage, pancreatic fistula and abdominal collection are
frequent complications.49 Pancreatic fistulae rates ranged from 0
to 12% in different studies. The most common clinical complica-
NORMALS
51 patients
(72.8%)
INSUFFICIENTS
19 patients
(27.2%)
• Insufficiency: 25 patients (49.0%)
• Normal: 26 patients (51.0%)
• Cure: No
• Total: 44/70 patients
(62.9%)
(median follow-up in diagnosis:13 months)
Figure 4 Exocrine function evolution of patients during follow-up
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tion is pulmonary.47,49 Smoking is often associated with alcohol-
ism, which is the most frequent cause of CP. In this series, 96%
(n = 69) of patients were heavy smokers for a long period, which
may explain the presence of pulmonary complications.
Malnutrition is often present in patients with CP, but there are
many tools to assess patients’ nutritional status, such as serum
albumin level and BMI. Serum albumin is a good and simple
predictor of surgical risk, and has a close correlation with the
degree of malnutrition.50 Hypoalbuminemia was associated with
poor tissue healing, decreased collagen synthesis in the surgical
wounds or the anastomosis51 and impairment of immune
responses.52 Low albumin levels can be a good predictor of some
types of morbidity and an independent predictor of poor surgical
outcomes, especially sepsis and major infections.53 Gibbs et al.
reported that a decrease in serum albumin from concentrations
greater than 4.6 g/dl to less than 2.1 g/dl was associated with an
exponential increase in mortality rates from less than 1% to 29%
and in morbidity rates from 10% to 65% after non-cardiac sur-
gery.54 In the present study, severe hypoalbuminemia (<2.5 g/dl)
was an risk factor for post-operative infections. In this series,
pre-operative nutritional recovery has been fundamental and
mandatory for these patients to decrease surgical morbidity, espe-
cially infections.
The long-term results related to pain control are in agreement
with other studies, with 91.4% of patients pain free for a follow-up
of 77.0 months (Table 5). Because it is a subjective symptom,
evaluation of pain control as a criterion of surgical success in the
post-operative follow-up has to be looked at with caution, as it
may suffer interference from a number of psychological and social
factors. The coexistence of mental disorders in patients with alco-
holism and those dependent on narcotics can interfere with treat-
ment outcome. Therefore, the service routine requires the
cessation of alcohol, tobacco and narcotics abuse, and offers psy-
chosocial support for these patients to undergo the surgical pro-
cedure, so they can get better results not only concerning pain, but
also for the overall recovery of the patient. Furthermore, some
studies have shown that the return to alcoholismmay be a cause of
pain recurrence in some patients. Thus, over the years dealing
with patients with chronic pancreatitis, the authors have observed
that surgery is only part of a complex and multidisciplinary treat-
ment that should start preparing the patient for surgery, and
continue during the whole post-operative period. Unfortunately,
despite the monitoring of patients in the post-operative period,
one-third of patients returned to drinking alcohol, most of them
within the first year.
As for pancreatic function, it was observed during the moni-
toring of patients the failure of surgery to cease continuous deg-
radation of glandular function. In all, 49% of patients developed
new onset exocrine insufficiency, which is higher than values
reported in the studies of Keck et al.46 with 34%, and Pessaux
et al.49 with 33%. No patient presented reversal of the situation,
and among those who developed the deficiency, its appearance
was not delayed, which corroborated the failure of ductal decom-
pression in reversing the pathological status and interrupting the
progression of tissue injury. Maybe because of intervening in
organs greatly affected by the disease, a delay in the degradation or
preservation of glandular function was not seen in the current
series, as previously suggested by Nealon.11,12 Results showed con-
tinuous and gradual evolution of pancreatic functional impair-
ment after surgery.
Other series showed an appearance of diabetes de novo in
10% to 34%45–49 with this technique; after Whipple’s procedure,
the rate can range from 20% to 50%.34,35,55 In the current series,
at the time of surgery 11 patients (15.5%) were already diabetic,
which is a frequency similar to other published series, ranging
from 12% to 26%,9,45–49 except for Chaudhary et al.47 that showed
almost half of diabetic patients in surgery. The development of
diabetes de novo ranged from 10% to 34% in published studies,
which are values lower than the one observed in this series, of
36.7%. What could have raised this rate is the extreme aggres-
sion to pancreatic parenchyma caused by the median alcohol
intake of 278 g per day per patient for a long period in this
Table 5 Comparsion data of pain-free patients and follow-up in previously reported relevant patients cohorts undergoing Frey's procedure
Pain-free at the end
of follow-up (%)
Mean follow-up
(months)
No. of
patients
Frey and Amikura (1994)19 86.7 37 50
Izbicki et al. (1995)44 94 17 22
Amikura et al. (1997)56 90 25 11
Izbicki et al. (1998)43 90 24 31
Ho and Frey (2001)57 88 38.4 75
Kelemen and Horvath (2002)58 57.1 20.6 13
Falconi et al. (2006)45 88.8 60 40
Pessaux et al. (2006)49 88 15 34
Egawa et al. (2009)48 100 46 71
Keck et al. (2010)46 62 43 50
Present series 91.4 77.0 73
HPB 269
HPB 2011, 13, 263–271 © 2011 International Hepato-Pancreato-Biliary Association
series, which is significantly above the mean levels reported by
Falconi et al.45 (100 g per day).
It is important to note that despite the complications and the
inability to stop the deterioration of glandular function, the main
goal of surgery is to control abdominal pain, which was largely
achieved. This can be noticed in the increase of BMI at follow-up
compared with preoperatively, which is an indirect sign of
improved quality of life.
Conclusions
The results of the study confirmed that local resection of the head
with longitudinal pancreatojejunostomy as proposed by Frey has
high effectiveness in the treatment of pain in long-term follow-up,
combined with little interference in the disease course (endocrine
and exocrine function). Frey’s procedure should be considered as
the primary operation in patients with disabling pain as a result of
CP because it is safer, easier and presents less morbidity and
mortality than alternative techniques.
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